StreetInsider.com News Articles

QuidelOrtho to Report Second Quarter 2026 Financial Results

Fri, 24 Jul 2026 07:00:00 -0400

SAN DIEGO, July 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will report its financial results for the second quarter 2026 ended June 28, 2026, after the market closes on Thursday, August 6, 2026.

QuidelOrtho to Report Second Quarter 2026 Financial Results

Fri, 24 Jul 2026 07:00:00 -0400

QuidelOrtho to Report Second Quarter 2026 Financial Results

Fri, 24 Jul 2026 07:00:00 -0400

QuidelOrtho to Report Second Quarter 2026 Financial Results

Fri, 24 Jul 2026 07:00:00 -0400

Beyond Fentanyl: How the Drug Crisis Is Changing

Thu, 23 Jul 2026 09:21:00 -0400

SAN DIEGO, July 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 59 of its Science Bytes podcast examining how the drug overdose landscape continues to evolve and what laboratory and emergency department professionals need to know to support patient care. Based on new guidance from the Association for Diagnostics and Laboratory Medicine (ADLM), the episode explores the growing complexity of toxicology testing amid counterfeit medications, polysubstance use and emerging synthetic opioids.

Beyond Fentanyl: How the Drug Crisis Is Changing

Thu, 23 Jul 2026 09:21:00 -0400

Beyond Fentanyl: How the Drug Crisis Is Changing

Thu, 23 Jul 2026 09:21:00 -0400

Beyond Fentanyl: How the Drug Crisis Is Changing

Thu, 23 Jul 2026 09:21:00 -0400

Form 4 QuidelOrtho Corp For: Jul 15 Filed by: Young Micah W

Thu, 16 Jul 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260716/26779935.html

Form 4 QuidelOrtho Corp For: Jul 15 Filed by: Young Micah W

Thu, 16 Jul 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260716/26779935.html

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 19:31:00 -0400

SAN DIEGO, July 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)("QuidelOrtho"), a leading global provider of diagnostic solutions, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of restricted stock units ("RSUs") with respect to 356,555 shares of the Company's common stock (the "Inducement Grant") to Micah Young, the Company's Chief Financial Officer and principal financial officer. The Inducement Grant was granted pursuant to the Company's 2026 Inducement Plan and as an inducement material to Mr. Young's entering into employment with the

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 19:31:00 -0400

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 19:31:00 -0400

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 19:31:00 -0400

Form 3 QuidelOrtho Corp For: Jul 06 Filed by: Young Micah W

Wed, 15 Jul 2026 17:48:00 -0400

si-local-file:///var/storage/secattach/20260715/26775080.html

Form 3 QuidelOrtho Corp For: Jul 06 Filed by: Young Micah W

Wed, 15 Jul 2026 17:48:00 -0400

si-local-file:///var/storage/secattach/20260715/26775080.html

Form S-8 QuidelOrtho Corp

Mon, 13 Jul 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260713/26762716.html

Form S-8 QuidelOrtho Corp

Mon, 13 Jul 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260713/26762716.html

Form SCHEDULE 13G QuidelOrtho Corp Filed by: Neuberger Berman Group LLC

Wed, 08 Jul 2026 11:12:00 -0400

si-local-file:///var/storage/secattach/20260708/26746046.html

Form SCHEDULE 13G QuidelOrtho Corp Filed by: Neuberger Berman Group LLC

Wed, 08 Jul 2026 11:12:00 -0400

si-local-file:///var/storage/secattach/20260708/26746046.html

QuidelOrtho (QDEL) PT Raised to $18 at Citi

Wed, 08 Jul 2026 05:47:37 -0400

Citi analyst Patrick Donnelly raised the price target on QuidelOrtho (NASDAQ: QDEL) to $18.00 (from $13.00) while maintaining a Neutral rating.

Form 4 QuidelOrtho Corp For: Jul 01 Filed by: Hanson Bryan Michael

Thu, 02 Jul 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260702/26727657.html

Form 4 QuidelOrtho Corp For: Jul 01 Filed by: Hanson Bryan Michael

Thu, 02 Jul 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260702/26727657.html

QuidelOrtho (QDEL) PT Raised to $12 at JPMorgan

Wed, 01 Jul 2026 08:02:00 -0400

JPMorgan analyst Casey Woodring raised the price target on QuidelOrtho (NASDAQ: QDEL) to $12.00 (from $11.00) while maintaining a Underweight rating.

Form 4 QuidelOrtho Corp For: Jun 25 Filed by: WIDDER KENNETH J

Mon, 29 Jun 2026 18:02:00 -0400

si-local-file:///var/storage/secattach/20260629/26707890.html